Clinical trials
2 active studies led by Strand Therapeutics Inc., of 2 in all
Source: ClinicalTrials.gov, Studies with Strand Therapeutics Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Strand Therapeutics Inc. in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Strand Therapeutics Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
2 active studies led by Strand Therapeutics Inc., of 2 in all
Source: ClinicalTrials.gov, Studies with Strand Therapeutics Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Markets we cover where free public records show Strand Therapeutics Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Strand Therapeutics Inc. is in.
Stories on the topics Strand Therapeutics Inc. works in.
WHO says only about half of patients in developed countries take long-term medicines as prescribed. Patient…
Read
Every vaccine, antibody and cell therapy must be tested for sterility, purity and viruses before it reaches…
Read
The first CAR-T cell therapy was approved in the US in August 2017. These living drugs can work when other…
ReadSearch all reports for Strand Therapeutics Inc. All companies